Voloridge Investment Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.1M Sell
310,515
-443,999
-59% -$31.3M 0.08% 338
2025
Q4
$50.8M Sell
754,514
-303,388
-29% -$20.4M 0.18% 142
2025
Q3
$77.6M Buy
+1,057,902
New +$70.3M 0.26% 101
2025
Q1
Sell
-18,321
Closed -$876K 1249
2024
Q4
$876K Buy
+18,321
New +$939K ﹤0.01% 1052
2024
Q3
Sell
-80,110
Closed -$4.19M 1244
2024
Q2
$4.19M Sell
80,110
-318,196
-80% -$14M 0.02% 797
2024
Q1
$16.2M Buy
398,306
+343,572
+628% +$12.9M 0.06% 384
2023
Q4
$2.02M Buy
+54,734
New +$2.06M 0.01% 828
2023
Q1
Sell
-212,076
Closed -$12.1M 1450
2022
Q4
$12.1M Buy
212,076
+140,847
+198% +$7.21M 0.07% 382
2022
Q3
$2.82M Sell
71,229
-296,894
-81% -$13.1M 0.02% 872
2022
Q2
$16.2M Buy
368,123
+225,287
+158% +$9.74M 0.08% 317
2022
Q1
$5.7M Sell
142,836
-112,950
-44% -$4.02M 0.03% 593
2021
Q4
$10.3M Buy
255,786
+141,961
+125% +$5.3M 0.06% 455
2021
Q3
$4.63M Buy
+113,825
New +$4.76M 0.03% 713
2021
Q1
Sell
-204,136
Closed -$8.72M 1503
2020
Q4
$8.72M Sell
204,136
-169,237
-45% -$6.08M 0.07% 308
2020
Q3
$9.81M Buy
373,373
+78,200
+26% +$2.18M 0.08% 268
2020
Q2
$7.91M Buy
+295,173
New +$6.66M 0.09% 249
2020
Q1
Sell
-99,168
Closed -$1.76M 1212
2019
Q4
$1.76M Buy
+99,168
New +$1.72M 0.03% 517

Other funds holding HALO

Voloridge Investment Management's HALO Position: Q1 2026 in Review

Voloridge Investment Management reduced its Halozyme (HALO) stake by 59% in Q1 2026, selling an estimated $31.3M and leaving 310,515 shares worth $20.1M. The position accounts for 0.08% of the portfolio, ranked #338.

Voloridge Investment Management first reported a position in HALO in Q4 2019 and has held it in 17 quarters since. The position peaked at $77.6M in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Voloridge Investment Management held 310,515 shares of Halozyme worth $20.1M as of Q1 2026.
  • Voloridge Investment Management sold 443,999 Halozyme shares in Q1 2026, an estimated $31.3M.
  • Halozyme made up 0.08% of Voloridge Investment Management's portfolio in Q1 2026, its #338 holding.
  • Voloridge Investment Management first reported a position in Halozyme in Q4 2019 and has held it in 17 quarters since.
  • Voloridge Investment Management's Halozyme position peaked at $77.6M in Q3 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.